Pricing Log in Create free account
Saturday 17 October 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 290.4%, free cash flow fell 36.2% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

285.42 2.02 +0.71%
Market cap
$500.8B
P/E
80.6×
Fwd P/E
27.8×
Dividend yield
2.42%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

AbbVie Inc. (ABBV) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, AbbVie Inc. (ABBV) trades at a P/E ratio of 80.6×. Over the past ten years it has ranged from 12.2× (March 2020) to 185× (October 2025); the current reading is higher than 90% of that period. That is above the Drug Manufacturers General industry median of 24.5× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 96.8× 30.76%
FY2024 74.0× 26.48%
FY2023 58.5× 138.31%
FY2022 24.6× 17.02%
FY2021 21.0× (43.97%)
FY2020 37.5× 123.42%
FY2019 16.8× (34.88%)
FY2018 25.8× (13.91%)
FY2017 29.9× 73.98%
FY2016 17.2× (9.45%)

Quarterly newest first

Period P/E ratio Change
Jun 2026 71.1× (33.65%)
Mar 2026 107× 10.66%
Dec 2025 96.8× (44.80%)
Sep 2025 175× 98.45%
42 more quarters

Against its own ten years

Low 12.2× High 185×
Ten-year median 27.7×
Current reading's percentile 89

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVS Novartis AG compare 22.6×
AZN AstraZeneca PLC compare 24.5×
AMGN Amgen Inc. compare 26.7×
JNJ Johnson & Johnson compare 29.6×
PFE Pfizer Inc. compare 38.9×
LLY Eli Lilly and Company compare 42.2×
ABBV AbbVie Inc. 80.6×
MRK Merck & Co., Inc. compare 117×
Drug Manufacturers General industry median 24.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ABBV